Kotak Alt Marks First Close Of Its Life Sciences Fund At INR 250 Cr

Kotak Alt Marks First Close Of Its Life Sciences Fund At INR 250 Cr

SUMMARY

The fund has a target corpus of INR 1,600 Cr (around $185 Mn), has seen participation from family offices, UHNIs (ultra high net worth individuals), industry veterans and other institutions

The fund will invest in early to growth stage startups operating in the life sciences space which includes medical devices, digital health, consumer wellness, diagnostics and delivery

In the past two years, the Kotak Mahindra Group’s alternative assets management entity has invested a total of INR 4,000 Cr in the healthcare sector

Kotal Alternate Asset Managers (Kotak Alt), has made the first close of its life sciences fund at INR 250 Cr (around $29 Mn).

The fund, with a target corpus of INR 1,600 Cr (around $185 Mn), has seen participation from family offices, UHNIs (ultra high net worth individuals), industry veterans and other institutions.

The fund will invest in early to growth stage startups operating in the life sciences space which includes medical devices, digital health, consumer wellness, diagnostics and delivery, Kotak Alt said in a statement.

In the past two years, the Kotak Mahindra Group’s alternative assets management entity has invested a total of INR 4,000 Cr in the healthcare sector. Along with financial backing, it also aims to lend support to selected startups in differentiating themselves from other players in the market.

“Life sciences is a core sector where the firm deploys capital across the lifecycle of the company i.e. early, growth and late stage,” said Ashish Ranjan, director private equity at Kotak Alt.

Founded in 2005, Kotak Alt claims to have raised and managed a total of over $22 Bn across various asset classes such as private equity, real estate, infrastructure, special situations, private credit and investment advisory.

In September last year, the investment firm backed D2C nutrition startup Nutrabay which raised $5 Mn and also participated in the $5 Mn Series A funding round of Biotech startup Ahammune Biosciences.

Kotak Alt’s healthcare and life sciences fund was incorporated in 2018 and till date it has made a total of 19 investments through that fund, according to its website.

The development comes close on the heels of many venture capital firms marking close of their  funds in the recent past.

Two days back, Bharat Value Fund announced the first close of its third investment fund at INR 1,250 Cr with a target corpus of INR 2,500 Cr to back resilient and asset backed businesses in multiple sectors.

Early this week it was reported that Sify Technologies is aiming to invest $5 Bn in India over a period of five years to build smaller AI inferencing facilities in 20 tier-II cities.

Moreover, last week Cornerstone Ventures also announced the first close of its second fund, which has a target corpus of $200 Mn, at about $40 Mn to back innovative B2B technology startups.

You have reached your limit of free stories
Become A Startup Insider With Inc42 Plus

Join our exclusive community of 10,000+ founders, investors & operators and stay ahead in india's startup & business economy.

2 YEAR PLAN
₹19999
₹7999
₹333/Month
UNLOCK 60% OFF
Cancel Anytime
1 YEAR PLAN
₹9999
₹4999
₹416/Month
UNLOCK 50% OFF
Cancel Anytime
Already A Member?
Discover Startups & Business Models

Unleash your potential by exploring unlimited articles, trackers, and playbooks. Identify the hottest startup deals, supercharge your innovation projects, and stay updated with expert curation.

Kotak Alt Marks First Close Of Its Life Sciences Fund At INR 250 Cr-Inc42 Media
How-To’s on Starting & Scaling Up

Empower yourself with comprehensive playbooks, expert analysis, and invaluable insights. Learn to validate ideas, acquire customers, secure funding, and navigate the journey to startup success.

Kotak Alt Marks First Close Of Its Life Sciences Fund At INR 250 Cr-Inc42 Media
Identify Trends & New Markets

Access 75+ in-depth reports on frontier industries. Gain exclusive market intelligence, understand market landscapes, and decode emerging trends to make informed decisions.

Kotak Alt Marks First Close Of Its Life Sciences Fund At INR 250 Cr-Inc42 Media
Track & Decode the Investment Landscape

Stay ahead with startup and funding trackers. Analyse investment strategies, profile successful investors, and keep track of upcoming funds, accelerators, and more.

Kotak Alt Marks First Close Of Its Life Sciences Fund At INR 250 Cr-Inc42 Media
Kotak Alt Marks First Close Of Its Life Sciences Fund At INR 250 Cr-Inc42 Media
You’re in Good company